Complement inhibitors for age-related macular degeneration-Reference-Cited by-同舟云学术

Complement inhibitors for age-related macular degeneration

Published:2023-06-14 Issue:6 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Tzoumas Nikolaos¹²,Riding George³⁴,Williams Michael A⁵,Steel David HW¹²

Affiliation:

1. Biosciences Institute; Newcastle University; Newcastle-upon-Tyne UK

2. Sunderland Eye Infirmary; Sunderland UK

3. Biosciences Institute, Newcastle University; Newcastle-upon-Tyne UK

4. North Middlesex University Hospital NHS Trust; London UK

5. School of Medicine, Dentistry and Biomedical Science, Queen’s University of Belfast; Belfast UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference174 articles.

1. Csaky KG Westby K Rezaei K Avacincaptad pegol, a novel C5 inhibitor, significantly reduces the mean rate of geographic atrophy growth in a pivotal clinical trial Investigative Ophthalmology and Visual Science 2020 61 7 ARVO E abstract 1943

2. C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2/3 trial;Jaffe;Ophthalmology,2021

3. Sheth V Avacincaptad pegol, a novel C5 inhibitor, demonstrates a continued reduction in the mean rate of geographic atrophy growth: 18-month results from the GATHER1 clinical trial Investigative Ophthalmology and Visual Science 2021 62 8 ARVO E abstract 333

4. CLG561 proof-of-concept study as a monotherapy and in combination with LFG316 in subjects with geographic atrophy (GA) clinicaltrials.gov/ct2/show/NCT02515942

5. Change in drusen volume as a novel clinical trial endpoint for the study of complement inhibition in age-related macular degeneration;Garcia Filho;Ophthalmic Surgery, Lasers and Imaging Retina,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treating patients with geographic atrophy: are we there yet?;International Journal of Retina and Vitreous;2023-11-20

2. Investigational drugs inhibiting complement for the treatment of geographic atrophy;Expert Opinion on Investigational Drugs;2023-10-31

3. Bruch’s Membrane: A Key Consideration with Complement-Based Therapies for Age-Related Macular Degeneration;Journal of Clinical Medicine;2023-04-14